Matthew L. Sherman
2015 - Acceleron Pharma
In 2015, Matthew L. Sherman earned a total compensation of $3.4M as Executive Vice President and Chief Medical Officer at Acceleron Pharma, a 543% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $161,886 |
|---|---|
| Option Awards | $1,407,107 |
| Salary | $413,033 |
| Stock Awards | $1,430,140 |
| Other | $5,000 |
| Total | $3,417,166 |
Sherman received $1.4M in stock awards, accounting for 42% of the total pay in 2015.
Sherman also received $161.9K in non-equity incentive plan, $1.4M in option awards, $413K in salary and $5K in other compensation.
Rankings
In 2015, Matthew L. Sherman's compensation ranked 2,677th out of 13,638 executives tracked by ExecPay. In other words, Sherman earned more than 80.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,677 out of 13,638 | 80th |
Division Manufacturing | 946 out of 5,187 | 82nd |
Major group Chemicals And Allied Products | 346 out of 1,857 | 81st |
Industry group Drugs | 271 out of 1,531 | 82nd |
Industry Biological Products, Except Diagnostic Substances | 49 out of 260 | 81st |
Source: SEC filing on April 15, 2016.
Sherman's colleagues
We found four more compensation records of executives who worked with Matthew L. Sherman at Acceleron Pharma in 2015.